Objective: c-FLIP is a natural homologue of caspase 8, and may antagonize activation of death pathways mediated by FADD. c-FLIP is highly expressed in the heart, and a recent report suggests that c-FLIP may protect against certain types of myocyte death. The present study was designed to define the expression patterns of c-FLIP in the heart. Methods: The expression pattern of c-FLIP in end-stage human hearts, and rat cardiomyocyte grafting models was analyzed by in situ hybridization, immunohistochemistry and TUNEL assay. In addition, to determine whether Fas-dependent pathway is active in cardiomyocytes in vitro, we examined whether activated monocytes can kill neonatal cardiomyocytes in a co-culture system. Results: c-FLIP mRNA and protein were abundantly expressed in normal cardiomyocytes from failing human heart. In animal models, c-FLIP protein was absent in TUNEL-positive grafted cardiomyocytes. Double staining demonstrated that c-FLIP-positive cells rarely had fragmented DNA, while TUNEL-positive cells rarely contained c-FLIP. Finally, activated monocytes induced death of neonatal rat cardiomyocytes via the Fas / FasL system. Conclusions: Loss of c-FLIP expression correlates with cardiomyocyte cell death. We hypothesize that diminished c-FLIP expression may predispose cardiomyocytes to apoptotic death.
a , b b a a 1. Introduction diated by death-dealing proteases (caspases), recognition of the factors responsible for the initiation or prevention of Recently, apoptosis has been proposed as a contributing apoptosis may provide new insights for developing stratecause of cardiac myocyte loss in ischemic-perfusion injury gies to regulate the survival or death of cells. [1] , myocardial infarction [2, 3] and end-stage heart failure The widely expressed protein Fas is a member of the [4, 5] . Ongoing myocyte apoptosis may lead to a progrestumor necrosis factor receptor family which can trigger sive deterioration in myocardial function, culminating in apoptosis [7] . Death receptor-induced apoptosis is an end-stage heart failure [6] . Since genetic and biochemical important event in tissue homeostasis as exemplified by the studies have now identified specific death pathways meaccumulation of T cells in Fas-deficient mice [7, 8] . However, Fas surface expression is not limited to the immune system [7] . The Fas / Fas ligand pathway has been impli-cated in cellular in a variety of tissues, including vascular washes in ice-cold PBS with 0.3 mM Na EDTA. Peripher-2 smooth muscle and endothelium [9, 10] . Recent studies al blood monocytes were isolated by magnetic cell sorting have shown that cells have not only caspases but also using CD14 immunobeads according to the manufacturer's ® specific proteins that block activation of caspases by death instructions (MACS / VarioMACS , Myltenyi Biotec, receptors. Interestingly, unlike the Bcl-2 family members Sunnyvale, CA, USA). Prior to incubation with magnetic which are potent inhibitors of apoptosis induced by growth CD14 immunobeads, the peripheral blood mononuclear factor withdrawal or g-irradiation [11] , these inhibitors cell fraction was separated from granulocytes and erythroappear to primarily block apoptosis induced by death cytes by centrifugation in Histopaque-1077 (Sigma, St. receptors [12] .
Louis, MO, USA). The monocytes were maintained in One class of death receptor inhibitors, identified first in RMPI 1640 plus either 0.1% human serum albumin viruses, is the caspase 8 (FLICE)-like inhibitor proteins (fraction V, Sigma, Pro) or 10% heat-inactivated fetal calf (v-FLIPs) [12] . v-FLIPs have homology to the death serum (BioWhittaker, Walkersville, MD, USA) as desigeffector domains (DEDs) of caspase 8 and 10, respectively nated, supplemented with 10 mM HEPES, 0.2 mM L- [12, 13] patients with both chronic heart failure and myocarditis 40-50% confluence and preincubated with Cr for 4 h. [20] [21] [22] [23] . Therefore, c-FLIP is of special interest in the After two washes with PBS, control (unactivated) monoheart because of its possible role in preventing apoptosis cytes, IC-activated monocytes were added to the wells. via the Fas pathway. To gain better insight into the Chromium release was measured after incubation for 24 h. possible protective role of c-FLIP in cardiomyocytes, we Neonatal cardiomyocytes were also preincubated with examined c-FLIP expression in cardiomyocyte grafting blocking IgG1 to Fas (ZB4, 1 mg / ml) to investigate the models. In addition, to explore the role of c-FLIP in both involvement of the Fas / FasL pathway in monocyte-inend-stage heart and animal models, we tested whether duced killing. An effector-to-target ratio of 100: transiently transfected with a c-FLIP expression vector that encodes full-length c-FLIP using lipofectamine (Gibco / All experiments were approved by the University of BRL) as described previously [19] . In addition, the staining Washington Animal Care Committee and were in accordpattern of c-FLIP was determined with MAG1 antibody by ance with federal guidelines. Syngeneic Fisher 344 rats using human vascular smooth muscle cells (VSMCs). (Simonsen Labs., Gilrey, CA, USA) were used for all
Immunostaining was performed by incubation of cells on grafting studies to prevent immune rejection. To identify glass slides with the MAG1 antibody (titer51:100) for 1 h the donor cardiomyocytes after grafting, the fetuses were at 378C. c-FLIP immunoreactivity was detected with a tagged in utero by continuous administration of BrdU to biotinylated anti-rabbit IgG secondary antibody and streptheir mothers for |1 week prior to delivery. Myocytes tavidin-fluoresceine. The cells were then stained with were isolated from 1-2-day-old pups by collagenase / panHoechst 33342 at a final concentration of 4 mg / ml for 30 creatin digestion as recently detailed [26] . The cells from min at 378C to identify cell nuclei. four to five consecutive 10-min digestions were pooled and then preplated for 30 min to reduce non-myocyte contami-2.6. Immunohistochemistry and TUNEL assay nation. Preparations averaged .90% cardiomyocytes, as evidenced by positive staining for sarcomeric isoforms of
The indirect avidin-biotin horseradish peroxidase and myosin heavy chain (MF-20 staining). Cells were used for alkaline phosphatase visualization method for immunografting within 2 h of isolation.
histochemistry and TUNEL assay has been described The cardiac cryoinjury model has recently been depreviously [28, 29] . The primary antibodies used for imscribed in detail [27] . In brief, adult male Fisher rats were munohistochemistry analyses include a polyclonal antianesthetized with ketamine-xylazine, intubated and mebody against c-FLIP (MAG1, 1:100 dilution) and a monochanically ventilated with room air. The heart was exposed clonal antibody recognizing all forms of sarcometric MHC via left thoracotomy. Cryoinjury was performed by placing in heart and adult skeletal muscle (MF20, Dako, Carpina 7-mm aluminium rod, precooled with liquid nitrogen, on teria, CA, USA, 1:1000). All antibodies were diluted in the anterior surface of the heart for 15 s. This resulted in a PBS containing 10% normal goat serum and 1% bovine disc-shaped zone of coagulation necrosis extending |1 cm serum albumin and incubated with the tissue sections for 1 laterally and approximately half way through the wall.
h at room temperature. For negative controls, non-immune Previous studies have shown that the events of inflammaisotype matched IgG was substituted for the primary tion and repair proceed virtually identically to myocardial antibody. In addition, competitive inhibition of the MAG1 infarction.
antibody with the immunizing peptide was performed by 6 For grafting studies, 4310 cardiomyocytes were suspreincubation for 30 min to 1 h at 378C. pended in 70 ml of serum free medium and used immediately. Grafting was performed using a Hamilton syringe 2.7. Double staining and a 30 gauge needle. The needle was inserted superficially into acutely necrotic muscle and the cell suspension
The first immunostaining using MAG1 antibody was injected. The chest then was closed and the rats allowed to developed with 3,39-diaminobenzidine (Sigma), which survive for defined intervals from 1 day to 2 weeks. After produced a brown reaction product. The second sequence sacrifice by pentobarbital overdose, the hearts were perfuof staining was performed on the same sections for sion fixed with methyl Carnoy's fixative (methanol-glacial TUNEL, with an avidin-alkaline phosphatase-substrate acetic acid-chloroform, 60:30:10, v / v / v) and routinely system and Vector Red (Vector ABC kit, Vector Labs.) processed and embedded in paraffin for histology. The which produced a red product. Full-length c-FLIP cDNA (1.4 kb) was subcloned into 2.5. c-FLIP antibody preparation, characterization and pBluescript II (Stragene, La Jolla, CA, USA) as described localization previously [17] . To generate anti-sense and sense RNA probes for in situ hybridization, plasmids were linearized A peptide of the N-terminal death-effector of c-FLIP with XbaI and KpnI, respectively. The plasmids were then 35 corresponding to amino acids 10-27 (sequence5 in vitro transcribed with S-labeled a-thio UTP (New EEALDTDEKEMLIFLCRD) was used to generate an England Nuclear-Dupont) following a modified method of affinity-purified rabbit polyclonal antibody, termed MAG1.
Wilcox et al. [30] . To improve penetration into sections The specificity of this antibody was confirmed as described during hybridization, transcripts were shortened by alpreviously [28] . As predicted, the antibody recognizes a 54 kaline hydrolysis to a calculated average length of 250 kDa c-FLIP in total cell lysates from cardiomyocytes. To bases.
2.9.
In situ hybridization GFP-c-FLIP fusion protein and examined the localization of fusion protein upon transfection. As shown in Fig. 1C , 35 In situ hybridization was performed with S-labeled transient transfection of GFP-c-FLIP fusion protein reriboprobes on 5-mm thick, deparaffinized sections of 4% sulted in uniform distribution of c-FLIP in cytoplasm and paraformaldehyde-fixed tissue. Riboprobes were separated nucleus of these cells. In contrast, immunofluorescent from unincorporated counts by passage over G-50 NICK staining with anti-tubulin antibody revealed a clear cytocolumns (Pharmacia, Piscataway, NJ, USA). The peak solic fibrillar distribution (Fig. 1D) . c-FLIP distribution radioactive fractions were treated with phenol-chloroform, was examined in end-stage human hearts, including hearts and the aqueous phase was precipitated with ethanol and from six patients with end-stage ischemic heart disease and resuspended to 300 000 cpm / ml in TE buffer. A 1-ml five patients with dilated cardiomyopathy. We and others volume of the riboprobe was mixed in 50 ml hybridization have previously reported abundant c-FLIP mRNA expresbuffer, applied to each section, and hybridizations were sions in human heart tissues by Northern hybridization performed at 558C overnight. Washes included treatment [14] [15] [16] [17] [18] [19] . Consistent with these observations, c-FLIP with RNAase A (20 mg / ml, Sigma) for 30 min at 378C mRNA was highly abundant in human cardiomyocytes and a stringent wash in 0.13SSC at 558C at 2 h. After from end-stage failing hearts (Fig. 2C) , as evidenced by in dehydration in graded alcohols and air drying, slides were situ hybridization of cells identified as cardiomyocytes by dipped in NTB2 emulsion (Eastman Kodak), exposed in positive staining for sarcomeric isoforms of myosin heavy the dark at 48C for 14 days, and developed as described chain, MF20 ( Fig. 2A) . No specific signal was detected in previously [30] . Hematoxylin was used as counterstain.
control hybridizations performed with sense c-FLIP riboprobes (Fig. 2D ). c-FLIP protein was also found in human 2.10. Western blotting cardiomyocytes with staining in the cytoplasm and, less commonly, the nucleus (Fig. 2B) . The immunizing peptide For detection of c-FLIP, whole cell lysates (30 mg / lane) completely abolished immunoreactivity (data not shown). and tissues including adult and fetal mouse heart were As previously reported by others in end-stage heart resolved by SDS-PAGE, transferred to PVDF membranes, failure [4, 5] , we observed TUNEL-positive cells in tissues and processed as previously described [31] . The protein from patients with end-stage heart failure. Most of these concentration of the lysate was determined using the Pierce TUNEL-positive cells were interstitial cells, but rare micro BCA reagents (Rockland, IL, USA). The MAG1 TUNEL-positive cardiomyocytes were present. Double antibody was used at a dilution of 1:100 representing a staining of end-stage heart samples with c-FLIP antibody final concentration of 1.4 mg / ml of peptide affinity and by TUNEL assay demonstrated that c-FLIP-positive purified IgG. The secondary antibody, an anti-rabbit IgG cells were TUNEL-negative in both ischemic and dilated labeled with horseradish-peroxidase, was used at a dilution cardiomyopathy. Representative tissues are shown in two of idiopathic cardiomyopathy.
Statistical analysis 3.2. c-FLIP expression and cell death following neonatal The cell death assay was repeated three times in separate
cardiomyocyte grafting experiments. Because data distribution in experimental groups was not normal, non-parametric statistical analysis Neonatal cardiomyocytes have a high spontaneous rate was performed (Mann-Whitney rank sum test), using SPSS of cell death after grafting into injured hearts [32, 33] , software. A P value less than 0.05 was considered which represents a possible useful model for anti-apoptotic significant.
therapies. We therefore examined the relationship between cell death and c-FLIP expression in neonatal cardiomyocyte grafts. We examined the relationship between 3. Results c-FLIP expression and cell death in neonatal cardiomyocytes transplanted into freeze-induced regions of rat 3.
c-FLIP expression and cell death in human heart
heart. The identity of grafted cells in the myocardium were tissue confirmed by staining for their BrdU tag in adjacent sections (Fig. 4A) . By TUNEL assay, 52% of transplanted We first tested cellular localization of c-FLIP protein by cells had fragmented DNA by 24 h. By double staining for performing immunofluorescent staining. As shown in Fig. TUNEL and c-FLIP, we found that TUNEL-positive 1A, using the MAG1 antibody, we found that c-FLIP myocytes were rarely c-FLIP positive (1.0%). In contrast, protein was both in cytoplasm and nucleus in human TUNEL-negative / c-FLIP-positive myocytes were obVSMCs. To confirm that c-FLIP protein can be found in served frequently (10.0%) (Fig. 4B and C) . both nuclei and cytoplasmic components, we constructed Given the strong expression of c-FLIP in myocardium in vivo and the diminished staining in grafted car-4. Discussion diomyocytes, we hypothesized that the cell isolation process might diminish c-FLIP expression. When c-FLIP Recently, Yaoita et al. reported in a rat model of expression was compared in adult and neonatal carmyocardial infarction that treatment with the caspase diomyocytes by Western blots immediately after isolation inhibitor z-VAD-fmk led to a limitation in infarct size and and after 1 day in culture, c-FLIP protein levels were an improvement of acute functional parameters [34] . markedly diminished by day 1 in culture (Fig. 5) .
Besides opening the door to the potential therapeutic use of caspase inhibitors, this finding focuses attention on the possible role of endogenous inhibitors of death pathways.
Activated monocytes kill neonatal cardiomyocytes
Our data on c-FLIP expression in heart support and extend the observations of Rasper et al. [18] , which showed that To examine whether the Fas-dependent pathway is 'Usurpin' (c-FLIP) was decreased in cardiac infarcts where active in isolated cardiomyocytes, we next tested whether TUNEL-positive myocytes and active caspase-3 expression activated monocytes can kill neonatal cardiomyocytes by were prominent following rat ischemia-reperfusion injury using a co-culture system. A chromium release assay was [18] . We showed that c-FLIP RNA and protein were used to determine the ability of monocytes, activated with abundantly expressed in human cardiomyocytes. Double immune complexes, to kill neonatal cardiomyocytes. As staining revealed that c-FLIP-positive cardiomyocytes shown in Fig. 6 , neonatal cardiomyocytes released signifiwere rarely apoptotic by TUNEL assay. Finally, activated 51 cant Cr into the media when co-cultured with monocytes. monocytes, which release soluble FasL following stimula-
51
This release of Cr was blocked by anti-Fas IgG1 (1 tion as we have previously reported [24] , could kill mg / ml) to a level comparable to the release caused by the neonatal cardiomyocytes which could be inhibited by addition of unstimulated monocytes to the neonatal carpreincubation with a blocking anti-Fas IgG1, suggesting diomyocytes. This suggests that neonatal cardiomyocyte that neonatal cardiomyocyte death is mediated by a Fasdeath was mediated by a Fas / FasL-dependent pathway. dependent pathway. The principal caveat in both our study and that of Rasper et al. is that loss of c-FLIP could be a consequence of protein degradation or loss, unrelated to the mechanism of cell death. Against this possibility, Rasper et al. failed to show degradation of endogenous 'Usurpin' in Jurkat lymphocytes induced to die by ligation of Fas [18] . In addition, Scaffidi et al. showed that c-FLIP is recruited to the CD95 death-induced signaling complex (DISC), where it is partially proteolyzed but remains detectable by immunoprecipitation during Fas-induced death [35] . Thus, absence of c-FLIP could result from a transcriptional event or a protein turnover event that precedes sensitivity to specific stimuli.
Interestingly, Thome et al. [12] found that c-FLIP protein levels correlated positively with resistance to Fas- 3 . Inverse correlation of c-FLIP expression and TUNEL positivity in end-stage human hearts. Sections were double stained using a combination of TUNEL assay and immunohistochemistry with c-FLIP antibody in end-stage human heart, including two hearts with ischemic cardiomyopathy (A-D) and two hearts with idiopathic dilated cardiomyopathy (E-H). Immunostaining for c-FLIP antibody yielded a brown color. The TUNEL stain was visualized by using an avidin-alkaline phosphatase substrate system, yielding red nuclei (fluorescent reaction product) as described [26] . Photomicrographs of slides examined by light microscopy (A,C,E,G) or fluorescence microscopy (B,D,F,H) are included. Note that c-FLIP-positive cells (brown) and TUNEL-positive cells (red) are distinct populations in all samples. Data are representative of eleven hearts, from six patients with ischemic cardiomyopathy and five patients with dilated cardiomyopathy. Bar in A5100 mm and applies to B-H. staurosporine or growth factor withdrawal. More recently, Algeciras-Schimnich et al. used the TAT membrane transport sequence to create a membrane-permeant chimera with c-FLIP. This chimera was able to protect Jurkat cells from Fas-mediated death [36] . These findings suggest that c-FLIP is a reasonable candidate for a regulator of cell death via the Fas-FasL pathway.
We have previously reported that monocytes / macrophages rapidly release soluble FasL following stimulation [24] . The role of soluble FasL, however, is still controversial. FasL is synthesized as a transmembrane, 37-kDa type II protein. This protein, however, can be cleaved by a metalloprotease to form a smaller, soluble molecule [37, 38] . Older studies suggested that soluble FasL may be ineffective in inducing apoptosis or could actually downregulate the proapoptotic activity of membrane-bound FasL [39, 40] . More recent studies, however, indicate that biologically active soluble FasL is rapidly released in vitro by normal human monocytes and macrophages during phagocytosis and following activation with phytohemagglutinin, immune complexes, or superantigen [41] . This be blocked by anti-Fas IgG1. If we allowed neonatal cardiomyocytes to stay in vitro for 24 h, they lost or mediated death observed in lymphocytes following activadiminished c-FLIP protein levels. In addition, in our in tion by phytohemagglutinin. The same cells also fail to vivo data only 1% of c-FLIP positive implanted cells recruit caspase 8 (FLICE) after presentation of FasL. In showed cell death, whereas 57% of c-FLIP negative contrast, they also found that c-FLIP does not protect from implanted cells were positive for TUNEL. So, c-FLIP may protect against Fas-mediated cardiomyocyte cell death. Finally, these ex vivo manipulations of neonatal cardiomyocyte grafts may provide a useful model for therapeutic interventions because we can examine whether an overexpression of anti-apoptotic molecule (e.g. adenoviral c-FLIP) in neonatal cardiomyocytes decreases the apoptotic cells in grafted cardiac tissues or not.
It is important that these in vivo studies of antiapoptotic molecules, except for the antisense studies of BCl-XL [42] , are phenomenological. The absence of c-FLIP in dying cells, indicated by simultaneous staining with TUNEL and an c-FLIP antibody, may be a consequence of protease generated during death rather than a cause. Although we have no direct way of answering this concern, in vitro studies with death receptor-activated death in lymphocytes show that c-FLIP is truncated to a form still recognized by the MAG-1 antibody or antibodies directed at the same peptide sequence [36] . A further caution is the use of death rather than giving an absolute value [44] . To provide 
